Lv61
2330 积分 2023-10-18 加入
Assessment of the evidence yield for the calibrated PP3/BP4 computational recommendations
6小时前
待确认
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
3天前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
3个月前
已完结
Targeted Next-Generation Sequencing in Succinate Dehydrogenase–Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR Pathway
8个月前
已完结
Sustained Response to Brigatinib in an Aggressive Relapsing Atypical Pituicytoma With ELM4-ALK Fusion
9个月前
已关闭
PROTAC protein degraders to drug the undruggable enter phase 3 trials
9个月前
已完结
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer
1年前
已完结
The Significance of International Federation of Gynecology and Obstetrics Grading in Microsatellite Instability-High and POLE-Mutant Endometrioid Endometrial Carcinoma
1年前
已完结
Resistance Mechanisms in ROS1-Positive Lung Cancer: New Insight into a Rare but Clinically Important Entity
1年前
已完结
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
1年前
已完结
皖公网安备34019202002308
